🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Today marks the beginning of #RSVAwarenessMonth, a cause that aligns with our ever-important mission at Enanta. We are committed to developing an antiviral treatment for RSV.

Wishing all of our Jewish colleagues and friends a happy and safe holiday season and a meaningful New Year. L'Shana Tova!

Today, Enanta is closed in honor of Indigenous Peoples' Day. We recognize the contributions and sacrifices that Indigenous communities have made and celebrate their rich cultural heritage. #IndigenousPeoplesDay2024

Today is National STEM Day, an opportunity to celebrate individuals working in Science, Technology, Engineering, and Math. We are proud to support #STEM and enjoy helping to inspire the next generation of students to consider a path in these fields. #STEMDay

We're grateful for the opportunity to work with amazing colleagues. Together we have the chance to help further our mission to transform the lives of patients with curative therapies. #HappyThanksgiving

As 2024 comes to an end, we reflect on the progress we’ve made this year and look forward to a successful 2025. We wish everyone a wonderful holiday season filled with joy and relaxation. #HAPPYHOLIDAYS

Our President and Chief Executive Officer, Jay R. Luly, Ph.D., will present a pipeline and business update at the @JPMorgan Healthcare Conference on Wednesday, January 15 at 8:15 am PT/11:15 am ET. bit.ly/408MQEZ

Last Wednesday marked what would have been Dr. Martin Luther King Jr.’s 95th birthday. We commemorate his life, legacy, and steadfast commitment to fighting for freedom, civil rights, and equality for all people. #MLKDay2025

This afternoon we issued our fiscal Q225 earnings release where we provided a financial and pipeline update. To read our release, visit here: ir.enanta.com/news-releases/…

May is AAPI Heritage Month, a time to honor the contributions Asian Americans and Pacific Islanders have made to our history and culture. At Enanta, we have a strong AAPI community and to recognize their heritage we had an AAPI-themed celebration outside. Who doesn't love AAPI

This #MemorialDay we reflect on the sacrifices made by the brave men and women who courageously gave their lives in service of our country. Their sacrifice, and that of their families, friends and loved ones must never be forgotten. We honor them today and always.

Today is the beginning of Pride Month. At Enanta, we are committed to creating an inclusive culture where our employees feel welcome and supported to bring their authentic selves to work every day. Happy Pride Month! #PrideMonth2025

This afternoon at 2 p.m. ET, our Chief Executive Officer, Jay R. Luly, Ph.D., will present at the Jefferies Global Healthcare Conference. Our Chief Product Strategy Officer, Tara L. Kieffer, Ph.D., will participate in the fireside chat portion. To access the webcast, visit here:

Today our partner AbbVie received FDA approval of an expanded indication for MAVYRET® (glecaprevir/pibrentasvir) as the first and only treatment for people with acute Hepatitis C virus. To read our press release, visit here: ir.enanta.com/news-releases/…

Juneteenth is an annual celebration commemorating the ending of slavery in the United States. Today we reflect on our countries racial struggles & also the triumph over slavery. Enanta recognizes the importance of diversity & inclusion in our workforce & is closed today in

We wish our entire Enanta community a safe and happy #IndependenceDay. As we celebrate this day, we remember all the heroes who fought for our freedom. Here's to the land of the free and the home of the brave. Happy Independence Day!

Today is #WorldHepatitisDay, an time to raise awareness of viral hepatitis. Congratulations to our partner AbbVie who recently received FDA approval of an expanded indication for MAVYRET® (glecaprevir/pibrentasvir) as the first and only treatment for people with #acute HCV.

Enanta management will participate in H.C. Wainwright & Co.’s "HCW@Home" series. The fireside chat will highlight our upcoming readout for Phase 2 study of zelicapavir in high-risk adults with #RSV and our immunology pipeline of #KIT and #STAT6 inhibitors. Register here: ct.to/eai44xz